Literature DB >> 30830681

Enzymatic construction of shRNA library from oligonucleotide library.

Seong Kyun Park1, Yun Kee2, Taehoon Ryu3, Hyoki Kim3, Byung Joon Hwang4.   

Abstract

BACKGROUND: Short hairpin RNAs (shRNAs) expressed from vectors have been used as an effective means of exploiting the RNA interference (RNAi) pathway in mammalian cells. Genome-scale screening with shRNA libraries has been used to investigate the relationship between genotypes and phenotypes on a large scale. Although several methods have been developed to construct shRNA libraries, their broad application has been limited by the high cost of constructing these libraries.
OBJECTIVE: We develop a new method that efficiently constructs a shRNA library at low cost, using treatments with several enzymes and an oligonucleotide library.
METHODS: The library of shRNA expression cassettes, which were cloned into a lentiviral plasmid, was produced through several enzymatic reactions, starting from a library of 20,000 different short oligonucleotides produced by microarray-based oligonucleotide synthesis.
RESULTS: The NGS sequence analysis of the library shows that 99.8% of them (19,956 from 20,000 sequences) were contained in the library: 63.2% of them represent the correct sequences and the rest showed one or two base pair differences from the expected sequences.
CONCLUSION: Considering the ease of our method, shRNA libraries of new genomes and of specific populations of genes can be prepared in a short period of time for genome-scale RNAi library screening.

Entities:  

Keywords:  High-throughput screen; Oligonucleotide library; RNAi; ShRNA library

Mesh:

Substances:

Year:  2019        PMID: 30830681     DOI: 10.1007/s13258-019-00800-2

Source DB:  PubMed          Journal:  Genes Genomics        ISSN: 1976-9571            Impact factor:   1.839


  27 in total

Review 1.  Killing the messenger: short RNAs that silence gene expression.

Authors:  Derek M Dykxhoorn; Carl D Novina; Phillip A Sharp
Journal:  Nat Rev Mol Cell Biol       Date:  2003-06       Impact factor: 94.444

Review 2.  Nucleic-acid therapeutics: basic principles and recent applications.

Authors:  Joanna B Opalinska; Alan M Gewirtz
Journal:  Nat Rev Drug Discov       Date:  2002-07       Impact factor: 84.694

3.  Optimization of an siRNA-expression system with an improved hairpin and its significant suppressive effects in mammalian cells.

Authors:  Makoto Miyagishi; Hidetoshi Sumimoto; Hiroyuki Miyoshi; Yutaka Kawakami; Kazunari Taira
Journal:  J Gene Med       Date:  2004-07       Impact factor: 4.565

Review 4.  Perspective: machines for RNAi.

Authors:  Yukihide Tomari; Phillip D Zamore
Journal:  Genes Dev       Date:  2005-03-01       Impact factor: 11.361

5.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.

Authors:  A Fire; S Xu; M K Montgomery; S A Kostas; S E Driver; C C Mello
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

6.  Short hairpin RNA (shRNA): design, delivery, and assessment of gene knockdown.

Authors:  Chris B Moore; Elizabeth H Guthrie; Max Tze-Han Huang; Debra J Taxman
Journal:  Methods Mol Biol       Date:  2010

7.  RNA interference in the pathogenic fungus Cryptococcus neoformans.

Authors:  Hong Liu; Tricia R Cottrell; Lynda M Pierini; William E Goldman; Tamara L Doering
Journal:  Genetics       Date:  2002-02       Impact factor: 4.562

8.  Expression of shRNA from a tissue-specific pol II promoter is an effective and safe RNAi therapeutic.

Authors:  Jeffery C Giering; Dirk Grimm; Theresa A Storm; Mark A Kay
Journal:  Mol Ther       Date:  2008-07-29       Impact factor: 11.454

9.  RNA interference in adult mice.

Authors:  Anton P McCaffrey; Leonard Meuse; Thu-Thao T Pham; Douglas S Conklin; Gregory J Hannon; Mark A Kay
Journal:  Nature       Date:  2002-07-04       Impact factor: 49.962

10.  An RNA polymerase II construct synthesizes short-hairpin RNA with a quantitative indicator and mediates highly efficient RNAi.

Authors:  Hongxia Zhou; Xu Gang Xia; Zuoshang Xu
Journal:  Nucleic Acids Res       Date:  2005-04-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.